Alpa Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

21.04

21.04

21.04

21.04

21.04

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

160.76

140.93

123.49

110.60

96.48

Loan funds

Secured loans

0.03

5.25

2.59

5.85

0.01

Unsecured loans

-

-

-

-

-

Total

181.84

167.22

147.12

137.49

117.53

Uses of funds

Fixed assets

Gross block

51.15

39.78

33.42

34.39

30.63

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

30.50

28.31

26.38

25.07

23.42

Net block

20.65

11.47

7.04

9.32

7.21

Capital work-in-progress

-

-

-

-

1.57

Investments

129.26

109.27

89.60

85.73

61.93

Net current assets

Current assets, loans & advances

83.07

71.68

80.86

70.09

79.52

Less : current liabilities & provisions

51.15

25.20

30.38

27.65

32.70

Total net current assets

31.93

46.47

50.48

42.44

46.82

Miscellaneous expenses not written

-

-

-

-

-

Total

181.84

167.22

147.12

137.49

117.53

Notes:

Book value of unquoted investments

117.87

98.01

6.66

6.17

10.43

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

6.65

10.57

3.25

5.28

5.28

Number of equity sharesoutstanding (Lacs)

210.41

210.41

210.41

210.41

210.41